The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin
Open accessAbstract
Vitiligo is an autoimmune disease of the skin causing disfiguring patchy depigmentation of the epidermis and, less commonly, hair. Therapeutic options for vitiligo are limited, reflecting in part limited knowledge of disease pathogenesis. Existing mouse models of vitiligo consist of hair depigmentation but lack prominent epidermal involvement, which is the hallmark of human disease. They are thus unable to provide a platform to fully investigate disease mechanisms and treatment. CD8+ T cells have been implicated in the pathogenesis of vitiligo and expression of interferon-gamma (IFN-γ) is increased in the lesional skin of patients, however it is currently unknown what role IFN-γ plays in disease. Here, we have developed an adoptive transfer mouse model of vitiligo using melanocyte-specific CD8+ T cells, which recapitulates the human condition by inducing epidermal depigmentation while sparing the hair. Like active lesions in human vitiligo, histology of depigmenting skin reveals a patchy mononuclear infiltrate and single-cell infiltration of the epidermis. Depigmentation is accompanied by accumulation of autoreactive CD8+ T cells in the skin, quantifiable loss of tyrosinase transcript, and local IFN-γ production. Neutralization of IFN-γ with antibody prevents CD8+ T cell accumulation and depigmentation, suggesting a therapeutic potential for this approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth-Dreese, F. A., Dellemijn, T. A., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 925
Antony, P. A., Piccirillo, C. A., Akpinarli, A., Finkelstein, S. E., Speiss, P. J., Surman, D. R., Palmer, D. C., Chan, C.-C., Klebanoff, C. A., Overwijk, W. W., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2591 · Cited by 760
Orchestrating the orchestrators: chemokines in control of T cell traffic
Bromley, S. K., Mempel, T. R., & Luster, A. D. (2008) · Nature Immunology · doi:10.1038/ni.f.213 · Cited by 593
Interstitial leukocyte migration and immune function
Friedl, P., & Weigelin, B. (2008) · Nature Immunology · doi:10.1038/ni.f.212 · Cited by 587
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
van den Boorn, J. G., Konijnenberg, D., Dellemijn, T. A. M., Wietze van der Veen, J. P., Bos, J. D., Melief, C. J. M., Vyth-Dreese, F. A., & Luiten, R. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.32 · Cited by 543
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Andersen, M. H., Schrama, D., thor Straten, P., & Becker, J. C. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700001 · Cited by 484
High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1203 · Cited by 460
Taïeb, A., & Picardo, M. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0804388 · Cited by 352
Zhang, S., Boisson‐Dupuis, S., Chapgier, A., Yang, K., Bustamante, J., Puel, A., Picard, C., Abel, L., Jouanguy, E., & Casanova, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00698.x · Cited by 321
A Role for CD103 in the Retention of CD4+CD25+ Treg and Control of Leishmania major Infection
Suffia, I., Reckling, S. K., Salay, G., & Belkaid, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5444 · Cited by 316
Lymphocytes, neuropeptides, and genes involved in alopecia areata
Gilhar, A., Paus, R., & Kalish, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31942 · Cited by 306
Wańkowicz-Kalińska, A., van den Wijngaard, R. M. J. G. J., Tigges, B. J., Westerhof, W., Ogg, G. S., Cerundolo, V., Storkus, W. J., & Das, P. K. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069521.42488.1b · Cited by 262
Random migration precedes stable target cell interactions of tumor-infiltrating T cells
Mrass, P., Takano, H., Ng, L. G., Daxini, S., Lasaro, M. O., Iparraguirre, A., Cavanagh, L. L., von Andrian, U. H., Ertl, H. C. J., Haydon, P. G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060710 · Cited by 229
Self-citationKunisada, T., Lu, S.-Z., Yoshida, H., Nishikawa, S., Nishikawa, S.-I., Mizoguchi, M., Hayashi, S.-I., Tyrrell, L., Williams, D. A., Wang, X., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1565 · Cited by 208
Gilhar, A., Assy, B., Shalaginov, R., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01583.x · Cited by 156
Elso, C. M., Roberts, L. J., Smyth, G. K., Thomson, R. J., Baldwin, T. M., Foote, S. J., & Handman, E. (2003) · Genes and Immunity · doi:10.1038/sj.gene.6364042 · Cited by 143
Gregg, R. K., Nichols, L. A., Chen, Y., Lu, B., & Engelhard, V. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902778 · Cited by 121
Vitiligo and the melanocyte reservoir
Rafael Falabella, F. (2009) · Indian Journal of Dermatology · doi:10.4103/0019-5154.57604 · Cited by 92
Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking?
Marelli‐Berg, F. M., & Jarmin, S. J. (2004) · Immunology Letters · doi:10.1016/s0165-2478(04)00082-3 · Cited by 60
Cited by
Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60763-7 · Cited by 943
Bergqvist, C., & Ezzedine, K. (2020) · Dermatology · doi:10.1159/000506103 · Cited by 799
CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin
Cheuk, S., Schlums, H., Gallais Sérézal, I., Martini, E., Chiang, S. C., Marquardt, N., Gibbs, A., Detlofsson, E., Introini, A., Forkel, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.009 · Cited by 678
“, 2008), whereas vitiligo presents with persistent depigmentations attributed to local interferon-g (IFN-g) production and T cell-mediated killing of melanocytes (Harris et al., 2012; Rashighi et al., 2014; van den Boorn et al., 2009).”
Vitiligo: Mechanisms of Pathogenesis and Treatment
Frisoli, M. L., Essien, K., & Harris, J. E. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100919-023531 · Cited by 618
Self-citationJAK inhibitors in dermatology: The promise of a new drug class
Damsky, W., & King, B. A. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.005 · Cited by 530
Metadata
- Authors
- Harris, J. E., Harris, T. H., Weninger, W., John Wherry, E., Hunter, C. A., & Turka, L. A.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 132
- Issue
- 7
- Pages
- 1869-1876
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2097803930
- Cited by
- 389
- References
- 20
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.